Product Name: Kallistatin antibody [N2C2], Internal
Applications: ICC/IF, IHC-P, WB
Predicted Target Size: 49 kDa (note) (4)
Positive Controls: HCT116
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
Background: Inhibits human amidolytic and kininogenase activities of tissue kallikrein. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and generation of a small C-terminal fragment of the inhibitor due to cleavage at the reactive site by tissue kallikrein.
Synonyms: KAL antibody, KLST antibody, KST antibody, PI4 antibody, kallistatin antibody, SERPINA4 antibody, serpin A4 antibody, kallikrein inhibitor antibody, “serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 antibody”, protease inhibitor 4 (kallistatin) antibody, peptidase inhibitor 4 antibody, “serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 antibody”
Cellular Localization: Secreted
CAS NO: 1198768-91-0
Product: Erythromycin Ethylsuccinate
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human Kallistatin. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27341130?dopt=Abstract
